Range
7.4 - 7.79
Vol / Avg.
7.9K/18.3K
Div / Yield
-
52 Wk
6.69 - 37.7
Mkt Cap
276.1M
Payout Ratio
-
Open
7.51
P/E
3
Shares
35.9M
Outstanding
35.9M
Total Float
23.9M
VectivBio Holding AG is a clinical stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need. The product candidate is apraglutide, which is a next generation, long-acting synthetic peptide analog of glucagon-like peptide-2, or GLP-2, which is developed as a differentiated therapeutic for a range of rare GI diseases, with an initial focus on short bowel syndrome.

Related Companies

TickerCompanyChg %Mkt Cap
VECTVectivBio Holding3.77%276.1M

VectivBio Holding Questions & Anwsers

Q

How do I buy VectivBio Holding (VECT) stock?

A

You can purchase shares of VectivBio Holding (NASDAQ: VECT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VectivBio Holding's (VECT) competitors?

A

There are no as such competitors for VectivBio Holding.

Q

What is the target price for VectivBio Holding (VECT) stock?

A

There is no analysis for VectivBio Holding

Q

Current Stock Price for VectivBio Holding (VECT)?

A

The stock price for VectivBio Holding (NASDAQ: VECT) is $7.7 last updated Fri Sep 24 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does VectivBio Holding (VECT) pay a dividend?

A

There are no upcoming dividends for VectivBio Holding.

Q

When is VectivBio Holding (NASDAQ:VECT) reporting earnings?

A

VectivBio Holding does not have any upcoming earnings scheduled.

Q

Is VectivBio Holding (VECT) going to split?

A

There is no upcoming split for VectivBio Holding.

Q

What sector and industry does VectivBio Holding (VECT) operate in?

A

VectivBio Holding is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.